Comparative Evaluation of Safety and Immune Activity of New Immunotherapeutic Agents for HDM Allergic Rhinitis Patients

Clinical trial NCT05525650 · UNKNOWN

Trial details

NCT number: NCT05525650
Sponsor: RAPHAS
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Mite Allergy Rhinitis, Allergic House Dust Mite Rhinitis

Start date: 2022-01-20
Primary completion: 2024-12-21
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.